NSC139021 (CAS No 1147-56-4) is a compound within the category of biomedical research chemicals primarily studied for its potential effects on cellular pathways involved in cancer treatment Originating from targeted synthesis efforts NSC139021 is known to interact with specific signaling pathways potentially inhibiting the proliferation of cancer cells Its mechanism often involves disruption of cellular replication processes leading to cell cycle arrest or apoptosis The compound exhibits activity in the nanomolar to low micromolar range indicating its potency in laboratory settings It is frequently used in in vitro studies involving various cancer cell lines and in vivo animal models to assess its efficacy and therapeutic potential NSC139021 is also employed in drug screening programs aimed at discovering novel anticancer agents Experimental concentrations typically depend on the specific research design allowing flexibility in use across different experimental setups